Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 940-786-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In cases where no data were available on the target substance, Benzene, C15-16-alkyl derivs., data were read across from a structurally related material (the test substance).
In vitro studies:
There are four key studies that examine the potential for mutagenicity of read-across source substances for Benzene, C15-16-alkyl derivs., using several in vitro methods. In the first key study (Robinson and Nair 1992), Salmonella typhimurium strains TA 1535, TA 100, TA 1537, and TA 98 were exposed to test substance concentrations of 10, 40, 200, 1000, 3000 and 10,000 µg/plate. DMSO was used as a solvent. The positive controls used were 9-aminoacridine, sodium nitrite, benzo(a)pyrene, 2-acetylaminofluorene, and 2-nitrofluorene. No reproducible, dose-response related positive results were seen in the treatment groups and therefore the results were considered negative both with and without activation. A significant increase in revertants per plate was seen in the positive controls, demonstrating the validity of the test. Therefore, the test substance is not mutagenic.
The second key study (Robinson and Nair 1992) determined the mutagenicity of the test substance. Salmonella typhimurium strains TA 1535, TA 100, TA 1537, and TA 98 were exposed to concentrations of 3, 12, 60, 300, 1000, and 3000 µg/plate of test substance. DMSO was used as a solvent. The positive controls used were 2-acetylaminofluorene, 9-aminoacridine, 4-nitroquinoline-N-oxide, sodium nitrite, and benzo(a)pyrene. No positive results were seen in the treatment groups. The results were considered negative with and without activation. The expected increase in revertants per plate was seen in the positive controls. The test substance is not mutagenic.
The third key study (Robinson and Nair 1992a) examined the potential of the test substance to cause mutations in mammalian cells. Chinese hamster ovary cells were exposed to 11 concentrations ranging from 100 to 2000 µL/mL of test substance both in the presence and absence of metabolic activation. Ethanol was used as a vehicle. Ethylmethanesulfonate, benzo(a)pyrene, and dimethylnitrosamine were used as positive controls. Cytotoxicity was seen at concentrations of 1000 µg/mL and above with metabolic activation and 250 µg/mL and above without metabolic activation. No significant increase in mutation frequencies was seen in treatment groups. The test substance is not mutagenic to mammalian cells.
The fourth key study (Robinson and Nair 1992b) examined the potential of the test substance to cause mutations in mammalian cells. Again, Chinese hamster ovary cells were exposed to 11 concentrations ranging from 100 to 2000 µL/mL of test substance both in the presence and absence of metabolic activation. Ethanol was used as a vehicle. Ethylmethanesulfonate, benzo(a)pyrene, and dimethylnitrosamine were used as positive controls. Cytotoxicity was seen at concentrations of 500 µL/mL and above both with and without metabolic activation. No significant increase in mutation frequencies was seen in treatment groups. The test substance is not mutagenic to mammalian cells.
In vivo studies:
The first key study (Robinson and Nair 1992a) examined the potential of the test substance to cause chromosome aberrations in vivo. Groups of 18-24 male and female rats were given doses of 2000, 6000, or 12,700 mg/kg of test substance. Negative control animals were given corn oil (vehicle) only. Positive control animals were given 40 mg/kg cyclophosphamide. Animals were sacrificed at 6, 12, 24, and 48 hrs after exposure. The bone marrow cells were then removed and examined for chromosome aberrations. There was significant mean body weight loss in animals treated with 12,700 mg/kg bw in both males and females. Males in the 6000 mg/kg dose level also showed weight loss. However, no significant increase in chromosomal aberrations was seen in any treatment group. Therefore, the test substance is not clastogenic.
The second key study (Robinson and Nair 1992b) examined the potential of the test substance to cause chromosome aberrations in vivo. Groups of 18-24 male and female rats were given doses of 1200, 4000, or 12,700 mg/kg of test substance. Negative control animals were given corn oil (vehicle) only. Positive control animals were given 40 mg/kg cyclophosphamide. Animals were sacrificed at 6, 12, 24, and 48 hrs after exposure. The bone marrow cells were then removed and examined for chromosome aberrations. Significant mean body weight loss occurred only at the 12,700 mg/kg dose in both males and females. No significant increase in chromosomal aberrations was seen in any treatment group. The test substance is not clastogenic .
In the third of three key studies (Kuhnert 1989), groups of 15 female and 15 male mice were given a single dose of the test substance to determine the effect on bone marrow erythrocyte production. Five animals of each sex were sacrificed at 24, 48, and 72 hrs after exposure. Similar groups were exposed to cyclophosphamide (positive control), and water (negative control). All animals in the positive control group were sacrificed at 24 hours. Animals in the treatment group exhibited diarrhea and diuresis during the treatment period. There was a significant increase in the polychromatid erythrocytes/normochromatid erythrocytes ratio and PCE cells with micronucleus in the positive control group. There was no significant increase in either of these parameters in the treatment group. Analysis of the bone marrow showed no significant increase in either micronucleus or PCE in the treatment group as compared to negative controls. Therefore, the test substance is not clastogenic.
Short description of key information:
Four in vitro and three in vivo studies of read-across source substances for Benzene, C15-16-alkyl derivs. support the conclusion that the registered substance is neither mutagenic nor clastogenic.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.